Cardiovascular
Understanding the clinical application and stakeholder requirements of cardiovascular products
Clinical trials in the cardiovascular space have become more complex. You may be facing limited access to capital, growing scrutiny from pharma partners and payers, as well as new requirements from regulatory agencies — all with limited operational resources. Among other challenges, cardiovascular trials are often global with high enrollment, where there is significant competition for investigators and patients. Quintiles has the capital and operational expertise in cardiology required to drive the development, execution, and commercial success of your product.
Pharmaceutical and Biotech Companies
Our long-term relationships with academic key opinion leaders and investigators around the globe give you a competitive advantage to complete your study and meet your goal of time, quality, and cost commitments. Our therapeutic expertise will bring value to your product across the spectrum of fee-for-service projects, or with more highly integrated partnerships by providing:
- Phase II and III strategy and execution
- Phase III/IV global studies including industry leading
- Protocol feasibility and site identification capabilities
- Regulatory strategy and execution
- Development of a quality system
- Accurate safety reporting in the US and abroad
Device Manufacturers
From catheters, to combination products such as drug-eluting stents, and in-vitro diagnostics, our medical device group can walk you through the entire drug development process and take your product to market.
Contact us to learn more about the many ways we can support the commercial viability of your cardiovascular product.
